Maravai LifeSciences Holdings, Inc. MRVI Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s accounts payable?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported accounts payable of $8.54M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s accounts payable changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s accounts payable decreased by 10.4% year-over-year, from $9.53M to $8.54M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s accounts payable?
- Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s accounts payable has grown at a -4.6% compound annual growth rate (CAGR), from $38.58M to $31.96M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.